Profound Medical (PROF) Stock Statistics & Valuation Metrics

Profound Medical has a market cap or net worth of $238.08M. The enterprise value is $166.16M.

Profound Medical has 36,337,640 shares outstanding. The number of shares has decreased by -2.65% in one year.

Profound Medical’s return on equity (ROE) is -0.65 and return on invested capital (ROIC) is -31.11%.

The current PE Ratio of Profound Medical is ―. Profound Medical’s PEG ratio is -0.20.

In the last 12 months, Profound Medical had revenue of 16.38M and earned -43.32M in profits. Earnings per share was -1.43.

In the last 12 months, operating cash flow was -38.32M and capital expenditures -179.08K, giving a free cash flow of -38.50M billion.

Profound Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Profound Medical upcoming earnings date is Jul 30, 2026, After Close (Confirmed).

Profound Medical as a current ratio of 12.52, with Debt / Equity ratio of 12.56%

In the past 12 months, Profound Medical has paid 256.41K in taxes.

Profound Medical EV to EBITDA ratio is -6.54, with an EV/FCF ratio of -6.93.

Profound Medical has $50.33M in cash and marketable securities with $7.47M in debt, giving a net cash position of $42.86M billion.

Gross margin is 71.04%, with operating margin of -256.27%, and net profit margin of -264.44%.

The average price target for Profound Medical is $11.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy